These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21361794)
21. Isolationism is not the answer to bioterrorism. Singh JA; Singer PA Nature; 2002 Dec; 420(6916):605. PubMed ID: 12478264 [No Abstract] [Full Text] [Related]
22. [Biological security confronting bioterrorism]. Suárez Fernández G An R Acad Nac Med (Madr); 2002; 119(1):77-89; discussion 89-95. PubMed ID: 12197209 [TBL] [Abstract][Full Text] [Related]
24. The insider threat--a new aspect of biosecurity. Engells TE J Healthc Prot Manage; 2013; 29(2):16-25. PubMed ID: 24020316 [TBL] [Abstract][Full Text] [Related]
25. Biological and chemical bioterrorism agents. Porche DJ J Assoc Nurses AIDS Care; 2002; 13(5):57-64. PubMed ID: 12369391 [TBL] [Abstract][Full Text] [Related]
26. Accelerating Action in Global Health Security: Global Biosecurity Dialogue as a Model for Advancing the Global Health Security Agenda. Brizee S; Budeski K; James W; Nalabandian M; Bleijs DA; Becker SJ; Wallace-Sankarsingh S; Ahumibe A; Agogo E; Ihekweazu C; Nikkari S; Ellis M; Gozzer E; Semesi IS; Masuku ZM; Ikram A; Tahir F; Makalinao I; Severance HA; van Passel MWJ; Cameron EE Health Secur; 2019; 17(6):495-503. PubMed ID: 31859570 [TBL] [Abstract][Full Text] [Related]
27. [Biological warfare and terror: prevention and countermeasures]. Hansen JE Ugeskr Laeger; 2010 Jan; 172(2):125-7. PubMed ID: 20074489 [TBL] [Abstract][Full Text] [Related]
29. Biological weapons as a strategic threat. Bracken P Public Health Rep; 2001; 116 Suppl 2(Suppl 2):5-8. PubMed ID: 11880661 [No Abstract] [Full Text] [Related]
30. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. A decade in biosecurity. Introduction. Inglesby TV; Henderson DA Biosecur Bioterror; 2012 Mar; 10(1):5. PubMed ID: 22455674 [No Abstract] [Full Text] [Related]
31. Biodefense R&D: anticipating future threats, establishing a strategic environment. Smith BT; Inglesby TV; O'Toole T Biosecur Bioterror; 2003; 1(3):193-202. PubMed ID: 15040197 [No Abstract] [Full Text] [Related]
32. Bridging the health security divide: department of defense support for the global health security agenda. Moudy RM; Ingerson-Mahar M; Kanter J; Grant AM; Fisher DR; Jones FR Biosecur Bioterror; 2014; 12(5):247-53. PubMed ID: 25254913 [TBL] [Abstract][Full Text] [Related]
33. Taking stock of the biodefense boom. Kaiser J Science; 2011 Sep; 333(6047):1214-5. PubMed ID: 21885751 [No Abstract] [Full Text] [Related]
34. The bioterrorism threat and dual-use biotechnological research: an Israeli perspective. Friedman D; Rager-Zisman B; Bibi E; Keynan A Sci Eng Ethics; 2010 Mar; 16(1):85-97. PubMed ID: 18563629 [TBL] [Abstract][Full Text] [Related]
36. Update on bioterrorism preparedness. Weber CJ Urol Nurs; 2004 Oct; 24(5):417-9. PubMed ID: 15575112 [TBL] [Abstract][Full Text] [Related]
37. [Bioterrorism: notes for an agenda in case of the unexpected]. Ponce de León-Rosales S; Lazcano-Ponce E; Rangel-Frausto MS; Sosa-Lozano LA; Huerta-Jiménez MA Salud Publica Mex; 2001; 43(6):589-603. PubMed ID: 11816236 [TBL] [Abstract][Full Text] [Related]
38. Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy. Binder P; Attre O; Boutin JP; Cavallo JD; Debord T; Jouan A; Vidal D Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):401-21. PubMed ID: 12818625 [TBL] [Abstract][Full Text] [Related]
39. Cutaneous manifestations of category A bioweapons. Aquino LL; Wu JJ J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993 [TBL] [Abstract][Full Text] [Related]